| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/03/2011 | CN101612180B Preparation method of polysaccharide extract of oleander and medical application of the polysaccharide extract |
| 08/03/2011 | CN101580507B Novel antitumor compound and preparation method and application thereof |
| 08/03/2011 | CN101550181B Human papilloma virus 16 type E7 protein functional antagonist peptide and encoding gene and application thereof |
| 08/03/2011 | CN101519436B Cyclic octapeptide compound in Hsisha sponge and application thereof |
| 08/03/2011 | CN101514222B Steroidal compound in Bugula neritina L. and use thereof |
| 08/03/2011 | CN101511793B Antitumor agent for undifferentiated gastric cancer |
| 08/03/2011 | CN101391043B Traditional Chinese medicine polysaccharide extract for suppressing lung cancer A549 cell proliferation and preparation method thereof |
| 08/03/2011 | CN101371876B Method for extracting and preparing total polysaccharide of compound abnormal savda mature agent |
| 08/03/2011 | CN101361914B Traditional Chinese medicine formulation for treating oral cancer |
| 08/03/2011 | CN101352465B Method for preparing ginseng health product medicinal granules |
| 08/03/2011 | CN101316590B Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 08/03/2011 | CN101300251B Benzimidazole thiophene compounds as PLK inhibitor |
| 08/03/2011 | CN101270163B Single-chain fragment antibody-polypeptide amalgamation protein and uses thereof |
| 08/03/2011 | CN101253180B 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands |
| 08/03/2011 | CN101244255B Thymus gland pentapeptide injection and uses thereof |
| 08/03/2011 | CN101184756B Isoflavonoid dimers |
| 08/03/2011 | CN101147801B Application of dexoyribozyme of target EBV-LMP1 in preparing medicine for treating EBV corresponding solid tumor |
| 08/03/2011 | CN101120959B Application of guhong injection for treating lung cancer |
| 08/03/2011 | CN101098703B Biodegradable linkers for molecular therapies |
| 08/03/2011 | CN101065360B Thermodynamically stable form of BAY 43-9006 tosylate |
| 08/03/2011 | CN101028322B Use of Maoliefengdou extract for preparing anti-cancer medicine |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use |
| 08/02/2011 | US7989491 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989489 Synergistic mixtures |
| 08/02/2011 | US7989477 Monocyclic heterocycles as kinase inhibitors |
| 08/02/2011 | US7989459 Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
| 08/02/2011 | US7989453 Antitumor agents; for example, N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indole-3-yl]glyoxylamide |
| 08/02/2011 | US7989442 (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine derivatives; contraception, hormone replacement therapy (HRT) or gynaecological disorders, adjuvant therapy in cancer |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| 08/02/2011 | US7988963 Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses |
| 08/02/2011 | US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | CA2538752C Quinazoline derivatives |
| 08/02/2011 | CA2537978C Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 08/02/2011 | CA2507262C Pharmaceutical composition containing bakuchiol for treating female osteoporosis |
| 08/02/2011 | CA2497119C A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 08/02/2011 | CA2486678C Non-viral gene delivery system |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2471577C Chemical compounds |
| 08/02/2011 | CA2449634C Somatostatin-dopamine chimeric analogs |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2442870C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
| 08/02/2011 | CA2441690C Method for the identification of antigenic peptides |
| 08/02/2011 | CA2417255C Medicament comprising amrubicin and an anti-her2 antibody for treating breast cancer |
| 08/02/2011 | CA2412650C Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2366723C Fatty acid-anticancer conjugates and uses thereof |
| 08/02/2011 | CA2364451C Agent for treatment of arthritic disease |
| 08/02/2011 | CA2349038C Methods of alleviating cancer symptoms |
| 08/02/2011 | CA2332655C Scce modified transgenic mammals and their use as models of human diseases |
| 08/02/2011 | CA2323757C Antibody variants and fragments thereof |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011091213A2 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 07/28/2011 | WO2011091154A2 Use of human erythrocytes for prevention and treatment of cancer dissemination and growth |
| 07/28/2011 | WO2011090940A1 Cyclodextrin-based polymers for therapeutic delivery |
| 07/28/2011 | WO2011090762A1 Heterodimer binding proteins and uses thereof |
| 07/28/2011 | WO2011090761A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | WO2011090754A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | WO2011090738A2 Type ii raf kinase inhibitors |
| 07/28/2011 | WO2011090349A2 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/28/2011 | WO2011090316A2 Novel pyrazinone derivatives having an apoptosis-inducing activity, and pharmaceutical compositions comprising same |
| 07/28/2011 | WO2011090297A2 Human adult stem cell for expressing anti-mdm2, and use thereof |
| 07/28/2011 | WO2011090283A2 Composition containing inhibitors of the expression or activity of sh3rf2 for preventing or treating cancer |
| 07/28/2011 | WO2011090266A2 Novel tumor antigen protein agr2 and tumor antigenic peptide thereof |
| 07/28/2011 | WO2011090005A1 Pharmaceutical preparation for colon cancer, and treatment method |
| 07/28/2011 | WO2011089995A1 Hydroxamic acid derivative and hdac8 inhibitor using same |
| 07/28/2011 | WO2011089921A1 Modified melk peptides and vaccines containing the same |
| 07/28/2011 | WO2011089507A1 A new series of artemisinin derivatives and process for preparation thereof |
| 07/28/2011 | WO2011089401A1 Crystalline forms of a purine derivative |
| 07/28/2011 | WO2011089400A1 Inhibitors of pi3 kinase |
| 07/28/2011 | WO2011089289A1 Use of amitriptyline as antitumour agent for the treatment of lung cancer |
| 07/28/2011 | WO2011089234A2 Method and composition |
| 07/28/2011 | WO2011088688A1 Polymer micelle medicine carrier comprising amino acid as stabilizer |
| 07/28/2011 | WO2011088605A1 Use of leptin in enhancing therapeutic efficacy of medroxyprogesterone acetate on liver cancer |
| 07/28/2011 | WO2011056037A9 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 07/28/2011 | WO2011054939A3 Compositions and methods for inhibiting expression of kif10 genes |
| 07/28/2011 | WO2011038160A3 Compositions and methods for silencing genes expressed in cancer |
| 07/28/2011 | WO2008137733A3 Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents |
| 07/28/2011 | US20110184418 Unsealed, Non-Colloidal Radiopharmaceutical Compositions and Methods for Treatment of Abnormal Tissue |
| 07/28/2011 | US20110184333 Photolabile caged transition metal complexes and methods of using the same |
| 07/28/2011 | US20110184145 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 07/28/2011 | US20110184073 Assay |
| 07/28/2011 | US20110184061 Thiocolchicine and colchicine analogs, methods of making and methods of use thereof |
| 07/28/2011 | US20110184057 Parenteral treatment with statins |
| 07/28/2011 | US20110184053 Novel nucleic acid transfer system |
| 07/28/2011 | US20110184051 Pharmacological applications of mitochondrial dna assays |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184045 Silencng and rig-i activation by dual function oligonucleotides |
| 07/28/2011 | US20110184041 PTHrP, ITS ISOFORMS AND ANTAGONIST THERETO IN THE DIAGNOSIS AND TREATMENT OF DISEASE |
| 07/28/2011 | US20110184036 Formulations of bendamustine |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |